drugset / Trial / NCT02073084

A Thorough Corrected QT Interval Trial

NCT02073084

Phase 1 Completed 56 enrolled Kowa Research Institute, Inc.
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to determine the effects of K-877 on ECG parameters with a focus on cardiac repolarization compared with placebo in healthy adult subjects.

Timeline

Start
2014-01
Primary completion
2014-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject K-877 Unknown
Subject Moxifloxacin Small molecule

Indications